乳腺癌磁导航前哨淋巴结检测的演变与优化:荟萃分析
该荟萃分析纳入20项比较研究,评估超顺磁性氧化铁纳米颗粒(SPIO)与放射性同位素(RI)±蓝染料(BD)在乳腺癌前哨淋巴结(SLN)定位中的性能。SPIO的检出率为97.5%,RI±BD为96.5%(风险比1.006,95%CI 0.992-1.019;P=0.376,高确定性证据)。SPIO可检出略多SLN(合并均值1.96 vs 1.89)且淋巴结检出率更高(94.1% vs 83.5%;RR 1.098,95%CI 1.058-1.140;P<0.001,低确定性证据)。术前注射超过24小时可提高检出率和淋巴结产量。
要点
- SPIO检出率与RI±BD相当,一致性高(99.0%),为高确定性证据。
- SPIO可检出更多SLN且淋巴结检出率更高,但证据确定性低。
- 术前注射超过24小时可提高SPIO检出率和淋巴结产量。
核心结论
- SPIO性能与RI±BD相当,术前注射可提高检出率和淋巴结产量,不影响一致性。
研究设计与样本
- 系统文献检索与荟萃分析,纳入20项比较研究,采用亚组和meta回归分析,按GRADE方法给出推荐。
主要发现
- SPIO检出率97.5%,RI±BD为96.5%(RR 1.006,95%CI 0.992-1.019;P=0.376,高确定性证据)。
- 一致性99.0%,反向一致性97.1%(率差0.003,95%CI -0.009-0.015;P=0.656,高确定性证据)。
- SPIO检出SLN合并均值1.96 vs 1.89,淋巴结检出率94.1% vs 83.5%(RR 1.098,95%CI 1.058-1.140;P<0.001,低确定性证据)。
- 皮肤染色率30.8%(极低确定性证据),可能通过更小剂量和瘤周注射预防。
关键数值与推荐
- 新辅助治疗、注射部位、注射体积或淋巴结转移负荷不影响检出率。
- meta回归显示术前注射超过24小时提高SPIO检出率和淋巴结产量。
临床怎么用
- SPIO可作为RI±BD的替代示踪剂用于乳腺癌前哨淋巴结定位。
- 建议术前超过24小时注射以提高检出率和淋巴结产量。
- 考虑使用更小剂量和瘤周注射以减少皮肤染色。
局限性
- 皮肤染色和MRI伪影是否因低剂量和瘤周注射减少仍需研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Superparamagnetic iron oxide nanoparticles (SPIO) have been used as a tracer for sentinel lymph node (SLN) localization in breast cancer, demonstrating comparable performance to the combination of radioisotope (RI) and blue dye (BD). METHODS: A systematic literature search and meta-analysis with subgroup and meta-regression analysis were undertaken to update the available evidence, assess technique evolution, and define knowledge gaps. Recommendations were made using the GRADE approach. RESULTS: In 20 comparative studies, the detection rate was 97.5 per cent for SPIO and 96.5 per cent for RI ± BD (risk ratio 1.006, 95 per cent c.i. 0.992 to 1.019; P = 0.376, high-certainty evidence). Neoadjuvant therapy, injection site, injection volume or nodal metastasis burden did not affect the detection rate, but injection over 24 h before surgery increased the detection rate on meta-regression. Concordance was 99.0 per cent and reverse concordance 97.1 per cent (rate difference 0.003, 95 per cent c.i. -0.009 to 0.015; P = 0.656, high-certainty evidence). Use of SPIO led to retrieval of slightly more SLNs (pooled mean 1.96 versus 1.89) with a higher nodal detection rate (94.1 versus 83.5 per cent; RR 1.098, 1.058 to 1.140; P < 0.001; low-certainty evidence). In meta-regression, injection over 24 h before surgery increased the SPIO nodal yield over that of RI ± BD. The skin-staining rate was 30.8 per cent (very low-certainty evidence), and possibly prevented with use of smaller doses and peritumoral injection. CONCLUSION: The performance of SPIO is comparable to that of RI ± BD. Preoperative injection increases the detection rate and nodal yield, without affecting concordance. Whether skin staining and MRI artefacts are reduced by lower dose and peritumoral injection needs to be investigated.
引用
- Pantiora E, Tasoulis MK, Valachis A, et al. Evolution and refinement of magnetically guided sentinel lymph node detection in breast cancer: meta-analysis. Br J Surg. 2023. PMID: 36560842. doi:10.1093/bjs/znac426
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。